Dexamethasone in severe COVID-19 infection: A case series

Mohamed Eliwa Hassan; Hasan MSN. Hasan; Kannan Sridharan; Adel Elkady; Mohamed MA. ElSeirafi

Respiratory Medicine Case Reports (Jan 2020)

Dexamethasone in severe COVID-19 infection: A case series

Mohamed Eliwa Hassan,
Hasan MSN. Hasan,
Kannan Sridharan,
Adel Elkady,
Mohamed MA. ElSeirafi

Affiliations

Mohamed Eliwa Hassan: Intensive Care Unit, Salmaniya Medical Complex, Ministry of Health, Manama, Bahrain
Hasan MSN. Hasan: Intensive Care Unit, Salmaniya Medical Complex, Ministry of Health, Manama, Bahrain; Corresponding author. ICU Chair & Senior Consultant, Salmaniya Medical Complex, Ministry of Health, Manama, Bahrain.
Kannan Sridharan: Department of Pharmacology & Therapeutics, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
Adel Elkady: Intensive Care Unit, Salmaniya Medical Complex, Ministry of Health, Manama, Bahrain
Mohamed MA. ElSeirafi: Intensive Care Unit, Salmaniya Medical Complex, Ministry of Health, Manama, Bahrain

Journal volume & issue: Vol. 31
p. 101205

Abstract

Read online

Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome.

Published in Respiratory Medicine Case Reports

ISSN: 2213-0071 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: http://www.journals.elsevier.com/respiratory-medicine-case-reports/

About the journal

Abstract

Keywords